XML 39 R29.htm IDEA: XBRL DOCUMENT v3.25.1
Stockholders' Equity (Tables)
3 Months Ended
Mar. 31, 2025
Equity [Abstract]  
Schedule of Key Assumptions used to Determine Fair Value of Options Granted
The assumptions used in determining the fair value of stock options granted were as follows:
Three Months Ended
March 31,
20252024
Volatility76.2 %84.2 %
Risk-free interest rate4.18 %4.07 %
Expected life (years)6.196.21
Dividend yield rate— %— %
Schedule of Stock Options Activity
A summary of stock option activity for the three months ended March 31, 2025, is presented below:
Weighted
WeightedAverage
AverageRemainingAggregate
StockExerciseContractualIntrinsic
OptionsPer ShareTerms (Years)Value
Outstanding as of December 31, 20246,151,069 $10.29 6.16$10,691 
Granted891,477 13.57 
Exercised(96,658)7.60 
Cancelled/forfeited(56,841)12.46 
Outstanding as of March 31, 20256,889,047 $10.73 6.41$14,618 
Vested and expected to vest at March 31, 20256,889,047 $10.73 6.41$14,618 
Exercisable as of March 31, 20254,180,826 $10.02 4.88$11,729 
Schedule of RSUs Activity
A summary of RSU activity for the three months ended March 31, 2025, is presented below:
Weighted Average
Grant Date
RestrictedFair Value
Stock UnitsPer Share
Outstanding as of December 31, 20243,378,867 $10.80
Granted886,713 13.42
Vested(854,614)9.67
Forfeited(69,795)11.18
Outstanding as of March 31, 20253,341,171 $11.78
A summary of PRSU activity for the three months ended March 31, 2025, is presented below:
Performance
Weighted
RestrictedAverage
StockGrant Date
UnitsFair Value
Outstanding as of December 31, 2024395,984 $12.12 
Granted353,663 13.58 
Outstanding as of March 31, 2025749,647 $12.81 
Schedule of Stock-based Compensation Expense
The following table summarizes stock-based compensation expense:
Three Months Ended
March 31,
20252024
Selling, general and administrative$5,749 $4,863 
Research and development179 216 
Total stock-based compensation expense$5,928 $5,079